Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Lin, Emily Pei-YingEmily Pei-YingLinHsu, Chih-YuanChih-YuanHsuChiou, Jeng-FongJeng-FongChiouBerry, LynneLynneBerryHorn, LeoraLeoraHornBunn, PaulPaulBunnCHIH-HSIN YANGPAN-CHYR YANGAdjei, Alex AAlex AAdjeiShyr, YuYuShyr2022-12-202022-12-202022-1215560864https://scholars.lib.ntu.edu.tw/handle/123456789/626629Survival benefit of immune checkpoint inhibitor (ICI) therapy in lung cancer is not fully understood.enCox HR; Cox-TEL; Immune checkpoint inhibitor; Long-term survival; PD-L1[SDGs]SDG3Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefitjournal article10.1016/j.jtho.2022.08.010360496562-s2.0-85142285676https://api.elsevier.com/content/abstract/scopus_id/85142285676